Germany· DE-A57-5d22304212e195ae
Thybon 100
A medicinal product containing liothyronine hydrochloride, registered in Germany by Sanofi-Aventis Deutschland Gmbh.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Liothyronine Hydrochloride
- Manufacturer
- Sanofi-Aventis Deutschland Gmbh
- Country
- Germany (DE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Liothyronine hydrochloride in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomCytomel 25microgram tabletsImported (United States)
- United StatesCytomelPfizer Laboratories Div Pfizer Inc
- NorwayCytomelPfizer Canada Inc.
- NetherlandsCytomel 12,5 microgram, tablettenACE Pharmaceuticals B.V.
- ItalyLIOTIR*orale 30 contenitori monodose 1 ml 10 mcg/mlIBSA FARMACEUTICI ITALIA Srl
- CanadaCYTOMELPFIZER CANADA ULC
- SwedenLiopent 5 mikrogram TablettPharmassist Ltd, Contract Reasearch Organisation
- FranceCYNOMEL 0,025 mg, comprimé sécableSANOFI WINTHROP INDUSTRIE
Authorised across Europe · EMA
The same active substance is authorised in 8 EEA countries. Names it is sold under:
- Denmark · Liopent
- France · Cynomel, Thybon
- United Kingdom (Northern Ireland) · Enolio, Iraksin
- Greece · T3
- Italy · Liotir
- Netherlands · Cytomel, Liopent
- Norway · Liothyronin Orifarm Healthcare
- Sweden · Liothyronin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b56c57a9-1ed1-4d50-b3b7-6da3e37c7e4e GET /v1/drugs/b56c57a9-1ed1-4d50-b3b7-6da3e37c7e4e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Oral Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Liothyronine Hydrochloride",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about liothyronine hydrochloride.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.